4//SEC Filing
Waynick Denelle J 4
Accession 0000899243-20-018356
CIK 0001552451other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 7:15 PM ET
Size
9.2 KB
Accession
0000899243-20-018356
Insider Transaction Report
Form 4
MyoKardia, Inc.MYOK
Waynick Denelle J
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-07-01+80,000→ 80,000 totalExercise: $93.84Exp: 2030-06-30→ Common Stock (80,000 underlying) - Award
Restricted Stock Units
2020-07-01+25,000→ 25,000 total→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]25% of the shares subject to this option shall vest and become exercisable on June 29, 2021, and the remainder shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date. In addition, in the event the Reporting Person's service relationship is terminated by the Issuer or any successor without Cause (as defined in the Issuer's stock plan) or for Good Reason (as defined in the Issuer's Change in Control and Severance Policy) within one year following the consummation of a Sale Event (as defined in the Issuer's stock plan), any unvested shares underlying the option will become fully vested as of the date of such termination in accordance with the Issuer's Change in Control and Severance Policy.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The RSUs shall vest in four annual installments after July 1, 2020, subject to the Reporting Person's continued service with the Issuer on each such vesting date. In addition, in the event the Reporting Person's service relationship is terminated by the Issuer or any successor without Cause (as defined in the Issuer's stock plan) or for Good Reason (as defined in the Issuer's Change in Control and Severance Policy) within one year following the consummation of a Sale Event (as defined in the Issuer's stock plan), any unvested units will become fully vested as of the date of such termination in accordance with the Issuer's Change in Control and Severance Policy.
Documents
Issuer
MyoKardia, Inc.
CIK 0001552451
Entity typeother
Related Parties
1- filerCIK 0001816440
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 7:15 PM ET
- Size
- 9.2 KB